The Impact of Tocilizumab Coverage on Health Equity for Inpatients with COVID-19 in the USA: A Distributional Cost-Effectiveness Analysis
S Kowal, KL Rosettie - PharmacoEconomics, 2024 - Springer
Objectives We conducted a distributional cost-effectiveness analysis to evaluate how
coverage of tocilizumab for inpatients with COVID-19 from 2021 to present impacted health …
coverage of tocilizumab for inpatients with COVID-19 from 2021 to present impacted health …
Cost-Effectiveness of Low-Dose Computed Tomography Screenings for Lung Cancer in High-Risk Populations: A Markov Model
CC Sheu, CC Wang, JS Hsu, WS Chung… - World Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Background Domestic and foreign studies on lung cancer have been oriented to the medical
efficacy of low-dose computed tomography (LDCT), but there is a lack of studies on the …
efficacy of low-dose computed tomography (LDCT), but there is a lack of studies on the …